Medistim ASA operates globally, providing specialized surgical guidance and quality assessment tools to the healthcare industry. The company's flagship MiraQ platform integrates ultrasound imaging with transit time flow measurement (TTFM) to reduce the risk of complications during complex cardiovascular procedures. Medistim's business model encompasses the sale and leasing of capital equipment, alongside recurring revenue from single-use and reusable surgical probes. While its proprietary technology is sold worldwide through direct sales forces in the US, Europe, and China, as well as a global distributor network, the company also maintains a regional distribution segment representing third-party medical device manufacturers in Scandinavia. Headquartered in Oslo, the company serves a growing market driven by the increasing adoption of quality assurance technologies in operating rooms.
